| Viren M Gohil, MD | |
|
450 W Highway 22, Barrington, IL 60010-1919 | |
| (847) 381-9600 | |
| Not Available |
| Full Name | Viren M Gohil |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 450 W Highway 22, Barrington, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225081037 | NPI | - | NPPES |
| 036104854 | Medicaid | IL | |
| P00473820 | Other | IL | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036104854 (Illinois) | Primary |
| Entity Name | Tri-county Emergency Physicians Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700810470 PECOS PAC ID: 2567412240 Enrollment ID: O20050131000438 |
News Archive
Cancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
More than 100 million Americans are expected to make a New Year's resolution this year. Losing weight and developing healthy habits, like eating healthy and exercising, are among the top three most common goals.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
› Verified 8 days ago
| Entity Name | Illinois Emergency Medicine Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003150962 PECOS PAC ID: 6103071808 Enrollment ID: O20130304000132 |
News Archive
Cancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
More than 100 million Americans are expected to make a New Year's resolution this year. Losing weight and developing healthy habits, like eating healthy and exercising, are among the top three most common goals.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
› Verified 8 days ago
| Entity Name | Crystal Lake Immediate Care Physicians Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538517198 PECOS PAC ID: 2961783139 Enrollment ID: O20161229001875 |
News Archive
Cancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
More than 100 million Americans are expected to make a New Year's resolution this year. Losing weight and developing healthy habits, like eating healthy and exercising, are among the top three most common goals.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Viren M Gohil, MD Po Box 98, Barrington, IL 60011-0098 Ph: (616) 975-1845 | Viren M Gohil, MD 450 W Highway 22, Barrington, IL 60010-1919 Ph: (847) 381-9600 |
News Archive
Cancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop.
A team led by scientists at The Scripps Research Institute has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
More than 100 million Americans are expected to make a New Year's resolution this year. Losing weight and developing healthy habits, like eating healthy and exercising, are among the top three most common goals.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
› Verified 8 days ago
Michael G Braun, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 | |
Mark Giacomin, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 | |
Dr. Ryan Salzman, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Il 22, Barrington, IL 60010 Phone: 847-842-4444 | |
Danish Haque, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 | |
Dr. Tracey L Hashemi, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 405 Lake Zurich Rd, Barrington, IL 60010 Phone: 847-381-5599 Fax: 847-381-8042 | |
Christopher P Mcswane, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-9600 |